[HTML][HTML] A review of cytokine-based pathophysiology of Long COVID symptoms
RN Low, RJ Low, A Akrami - Frontiers in Medicine, 2023 - frontiersin.org
The Long COVID/Post Acute Sequelae of COVID-19 (PASC) group includes patients with
initial mild-to-moderate symptoms during the acute phase of the illness, in whom recovery is …
initial mild-to-moderate symptoms during the acute phase of the illness, in whom recovery is …
[HTML][HTML] Molecular mimicry of NMDA receptors may contribute to neuropsychiatric symptoms in severe COVID-19 cases
V Vasilevska, PC Guest, HG Bernstein… - Journal of …, 2021 - Springer
Approximately 30% of individuals with severe SARS-CoV-2 infections also develop
neurological and psychiatric complaints. In rare cases, the occurrence of autoimmune …
neurological and psychiatric complaints. In rare cases, the occurrence of autoimmune …
Tunneling nanotubes provide a route for SARS-CoV-2 spreading
A Pepe, S Pietropaoli, M Vos, G Barba-Spaeth… - Science …, 2022 - science.org
Neurological manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection represent a major issue in long coronavirus disease. How SARS-CoV-2 …
CoV-2) infection represent a major issue in long coronavirus disease. How SARS-CoV-2 …
[HTML][HTML] Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal
GES Batiha, HM Al-Kuraishy, AI Al-Gareeb… - …, 2023 - Springer
Abstract In coronavirus disease 2019 (Covid-19) era, neuroinflammation may develop due
to neuronal tropism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …
to neuronal tropism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …
COVID-19 as a trigger of brain autoimmunity
Entry of SARS-CoV-2 into the central nervous system (CNS) activates microglia, triggering
chronic neuroinflammation and possibly neurodegeneration. The complex transcriptome of …
chronic neuroinflammation and possibly neurodegeneration. The complex transcriptome of …
[HTML][HTML] Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors
P Rzymski - Frontiers in Immunology, 2023 - frontiersin.org
COVID-19 vaccination is a life-saving intervention. However, it does not come up without a
risk of rare adverse events, which frequency varies between vaccines developed using …
risk of rare adverse events, which frequency varies between vaccines developed using …
[HTML][HTML] Brain diffusion alterations in patients with COVID-19 pathology and neurological manifestations
A Caroli, S Capelli, A Napolitano, G Cabrini… - NeuroImage: Clinical, 2023 - Elsevier
Background and objective COVID-19 neurological manifestations have been progressively
recognized. Among available MRI techniques, diffusion weighted imaging (DWI) shows …
recognized. Among available MRI techniques, diffusion weighted imaging (DWI) shows …
COVID‐19‐induced autoimmune thyroiditis: Exploring molecular mechanisms
Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) damages multiple
organs, including the thyroid, by direct invasion and cell entry via angiotensin‐converting …
organs, including the thyroid, by direct invasion and cell entry via angiotensin‐converting …
[HTML][HTML] Can SARS-CoV-2 infection lead to neurodegeneration and Parkinson's disease?
L Krey, MK Huber, GU Höglinger, F Wegner - Brain Sciences, 2021 - mdpi.com
The SARS-CoV-2 pandemic has affected the daily life of the worldwide population since
2020. Links between the newly discovered viral infection and the pathogenesis of …
2020. Links between the newly discovered viral infection and the pathogenesis of …
[HTML][HTML] Molecular mechanisms in the genesis of seizures and epilepsy associated with viral infection
Seizures are a common presenting symptom during CNS viral infections and can occur
during the initial phase of infection (“early” or acute symptomatic seizures), after recovery …
during the initial phase of infection (“early” or acute symptomatic seizures), after recovery …